Measuring L-dopa in plasma and urine to monitor therapy of elderly patients with Parkinson disease treated with L-dopa and a dopa decarboxylase inhibitor
- PMID: 8472357
Measuring L-dopa in plasma and urine to monitor therapy of elderly patients with Parkinson disease treated with L-dopa and a dopa decarboxylase inhibitor
Abstract
We have established a method for measuring L-dopa in plasma and urine, including the metabolites dopamine and L-dopac, using separation by ion-pair reversed-phase HPLC and quantification with an electrochemical detector. The assay was applied to the therapeutic monitoring of elderly patients with established Parkinson disease being treated with L-dopa plus a dopa decarboxylase inhibitor. Plasma L-dopa was evaluated in relation to dosage and postdose sampling time in 71 outpatients with Parkinson disease. L-Dopa concentrations were greatest in the patients taking the highest dosages prescribed and decreased significantly with increasing time after postdose sampling. Comparison of plasma L-dopa concentrations with a published therapeutic range established by intravenous administration of L-dopa was helpful in assessing the suitability of each patient's drug dosage, assessing patients' compliance, and avoiding overdosage but was not useful in the overall clinical assessment of progression of disease or of the long-term therapeutic response. Urine measurements confirmed the plasma concentrations but showed no further advantage. The recommended time for sample collection is between 1.5 and 3 h after the first morning dose. Plasma is the preferred matrix but if blood sampling is difficult, particularly from elderly/infirm individuals, an untimed urine collection could be used.
Similar articles
-
Optimization of the hydrolysis of conjugated L-DOPA, dopamine and dihydroxyphenylacetic acid in human urine for assay by high-performance liquid chromatography with electrochemical detection.Eur J Clin Chem Clin Biochem. 1997 Mar;35(3):229-35. doi: 10.1515/cclm.1997.35.3.229. Eur J Clin Chem Clin Biochem. 1997. PMID: 9127745
-
In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administration.J Neural Transm. 1976;38(3-4):181-91. doi: 10.1007/BF01249438. J Neural Transm. 1976. PMID: 956809
-
Improved high-performance liquid chromatographic analysis with double detection system for L-dopa, its metabolites and carbidopa in plasma of parkinsonian patients under L-dopa therapy.J Chromatogr. 1988 Dec 28;459:341-9. doi: 10.1016/s0021-9673(01)82046-x. J Chromatogr. 1988. PMID: 3243910
-
The pharmacology of Parkinson's disease: basic aspects and recent advances.Experientia. 1984 Nov 15;40(11):1165-72. doi: 10.1007/BF01946641. Experientia. 1984. PMID: 6437857 Review.
-
Determination of levodopa by chromatography-based methods in biological samples: a review.Anal Sci. 2022 Aug;38(8):1009-1017. doi: 10.1007/s44211-022-00132-4. Epub 2022 Jun 17. Anal Sci. 2022. PMID: 35715690 Review.
Cited by
-
DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration.J Clin Invest. 2024 Jul 16;134(17):e174199. doi: 10.1172/JCI174199. J Clin Invest. 2024. PMID: 39012703 Free PMC article.
-
Reusable graphite-based electrochemical sensors for L-dopa and dopamine detection.Mikrochim Acta. 2024 Mar 14;191(4):197. doi: 10.1007/s00604-024-06271-x. Mikrochim Acta. 2024. PMID: 38483622
-
Sensing of Catecholamine in Human Urine Using a Simple Colorimetric Assay Based on Direct Melanochrome and Indolequinone Formation.Sensors (Basel). 2023 Apr 13;23(8):3971. doi: 10.3390/s23083971. Sensors (Basel). 2023. PMID: 37112313 Free PMC article.
-
Electroanalytical Overview: The Determination of Levodopa (L-DOPA).ACS Meas Sci Au. 2023 Feb 3;3(2):84-97. doi: 10.1021/acsmeasuresciau.2c00071. eCollection 2023 Apr 19. ACS Meas Sci Au. 2023. PMID: 37090256 Free PMC article. Review.
-
Urinary neurotransmitter analysis and canine behavior assessment.Front Vet Sci. 2023 Feb 6;10:1124231. doi: 10.3389/fvets.2023.1124231. eCollection 2023. Front Vet Sci. 2023. PMID: 36814465 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical